{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T18:20:01Z","timestamp":1715970001231},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1038\/ja.2008.64","type":"journal-article","created":{"date-parts":[[2009,1,16]],"date-time":"2009-01-16T15:00:17Z","timestamp":1232118017000},"page":"485-488","source":"Crossref","is-referenced-by-count":2,"title":["Rifalazil and Derivative Compounds Show Potent Efficacy in a Mouse Model of H. pylori Colonization"],"prefix":"10.1038","volume":"61","author":[{"given":"David M","family":"Rothstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Mullin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klari","family":"Sirokman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen L","family":"S\u00f6ndergaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Starrla","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith K","family":"Gwathmey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"van Duzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher K","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFja200864_CR1","first-page":"960","volume-title":"Harrison's Principles of Internal Medicine\u201415th edition","author":"JC Atherton","year":"2001","unstructured":"Atherton JC, et al. Helicobacter pylori Infections. In Harrison's Principles of Internal Medicine\u201415th edition, Ed., Braunwald E. et al., pp. 960\u2013963, New York, McGraw-Hill ( 2001)"},{"key":"BFja200864_CR2","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1111\/j.1572-0241.1998.00684.x","volume":"93","author":"CW Howden","year":"1998","unstructured":"Howden CW, Hunt RH . Guidelines for the management of Helicobacter pylori infection. Am J Gastroenterol 93: 2330\u20132338 ( 1998)","journal-title":"Am J Gastroenterol"},{"key":"BFja200864_CR3","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1056\/NEJMra020542","volume":"347","author":"S Suerbaum","year":"2002","unstructured":"Suerbaum S, Michetti P . Helicobacter Pylori Infection. N Engl J Med 347: 1175\u20131186 ( 2002)","journal-title":"N Engl J Med"},{"key":"BFja200864_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1136\/bmj.320.7226.31","volume":"320","author":"WA de Boer","year":"2000","unstructured":"de Boer WA, Tytgat GNJ . Treatment of Helicobacter pylori infection. British Med J 320: 31\u201334 ( 2000)","journal-title":"British Med J"},{"key":"BFja200864_CR5","doi-asserted-by":"publisher","first-page":"463","DOI":"10.7326\/0003-4819-139-6-200309160-00008","volume":"139","author":"BJT McMahon","year":"2003","unstructured":"McMahon BJT, Hennessy W, Bensler JM, Bruden DL, Parkinson AJ, Morris JM, Hurlburt DA, Bruce MG, Sacco F, Butler JC . The relationship among previous antimicrobial use, antimicrobial resistance, and treatment outcomes for Helicobacter pylori infections. Ann of Int Med 139: 463\u2013469 ( 2003)","journal-title":"Ann of Int Med"},{"key":"BFja200864_CR6","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1086\/377206","volume":"37","author":"WM Wong","year":"2003","unstructured":"Wong WM, Gu O, Wang WH, Fung FM, Berg DE, Lai KC, Xia HH, Hu WH, Chan CK, Chan AO, Yuen MF, Hui CK, Lam SK, Wong BC . Effects of primary metronidazole and clarithromycin resistance to Helicobacter pylori on omeprazole, metronidazole, and clarithromycin tripletherapy regimen in a region with high rates of metronidazole resistance. Clin Inf Dis 37: 882\u2013889 ( 2003)","journal-title":"Clin Inf Dis"},{"key":"BFja200864_CR7","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1046\/j.1365-2036.2002.01276.x","volume":"16","author":"JP Gisbert","year":"2002","unstructured":"Gisbert JP, Pajares JM . Review article: Helicobacter pylori \u201crescue\u201d regimen when proton pump inhibitor-based triple therapies fail. Aliment Pharmacol Ther 16: 1047\u20131057 ( 2002)","journal-title":"Aliment Pharmacol Ther"},{"key":"BFja200864_CR8","first-page":"58","volume":"96","author":"F Perri","year":"2001","unstructured":"Perri F, Festa V, Clemente R, Villani MR, Quitadamo M, Caruso N, Bergoli ML, Andriulli A . Randomized study of two \u201crescue\u201d therapies for Helicobacter pylori-infected patients after failure of standard triple therapies. Am J Gastroenterol 96: 58\u201362 ( 2001)","journal-title":"Am J Gastroenterol"},{"key":"BFja200864_CR9","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1128\/AAC.43.5.1072","volume":"43","author":"JK Akada","year":"1999","unstructured":"Akada JK, Shirai M, Fujii K, Okita K, Nakazawa T . In vitro anti-Helicobacter pylori activities of new rifamycin derivatives, KRM-1648 and KRM-1657. Antimicrob Agents Chemother 43: 1072\u20131076 ( 1999)","journal-title":"Antimicrob Agents Chemother"},{"key":"BFja200864_CR10","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1128\/IAI.69.5.2902-2908.2001","volume":"69","author":"KA Eaton","year":"2001","unstructured":"Eaton KA, Kersulyte D, Mefford M, Danon SJ, Krakowka S, Berg DE . Role of Helicobacter pylori cag region genes in colonization and gastritis in two animal models. Infect Immun 69: 2902\u20132908 ( 2001)","journal-title":"Infect Immun"},{"key":"BFja200864_CR11","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/S0016-5085(97)70155-0","volume":"112","author":"A Lee","year":"1997","unstructured":"Lee A, O-Rourke J, Corazon de Ungria M, Robertson B, Daskalopoulos G, Dixon MF . A standardized mouse model of Helicobacter pylori infection; introducing the Sydney strain. Gastroenterol 112: 1386\u20131397 ( 1997)","journal-title":"Gastroenterol"},{"key":"BFja200864_CR12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10096-001-0672-2","volume":"21","author":"M Heep","year":"2002","unstructured":"Heep M, Lehn N, Branstatter B, Rieger U, Senzenberger S, Wehrl W . Detection of rifabutin resistance and association of rpoB mutations with resistance to four rifamycin derivatives in Helicobacter pylori. Eur J Clin Microbiol Infect Dis 21: 143\u2013145 ( 2002)","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"BFja200864_CR13","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1046\/j.1365-2036.1998.00425.x","volume":"12","author":"AF Goddard","year":"1998","unstructured":"Goddard AF . Review article: factors influencing antibiotic transfer across the gastric mucosa. Aliment Pharmacol Ther 12: 1175\u20131184 ( 1998)","journal-title":"Aliment Pharmacol Ther"},{"key":"BFja200864_CR14","doi-asserted-by":"publisher","first-page":"3658","DOI":"10.1128\/AAC.01087-05","volume":"50","author":"DM Rothstein","year":"2006","unstructured":"Rothstein DM, Farquhar RS, Sirokman K, Sondergaard KL, Hazlett C, Doye AA, Gwathmey JK, Mullin S, Van Duzer J, Murphy CK . Efficacy of novel rifamycin derivatives against rifamycin-sensitive and -resistant Staphylococcus aureus in murine models of infection. Antimicrob Agents Chemother 50: 3658\u20133664 ( 2006)","journal-title":"Antimicrob Agents Chemother"},{"key":"BFja200864_CR15","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1517\/13543784.15.6.603","volume":"15","author":"DM Rothstein","year":"2006","unstructured":"Rothstein DM, Shalish C, Murphy CK, Sternlicht A, Campbell LA . Development potential of rifalazil and other benzoxazinorifamycins. Expert Opin Investig Drugs 15: 603\u2013623 ( 2006)","journal-title":"Expert Opin Investig Drugs"},{"key":"BFja200864_CR16","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1046\/j.1365-2036.1998.00425.x","volume":"12","author":"AF Goddard","year":"1998","unstructured":"Goddard AF . Review article: factors influencing antibiotic transfer across the gastric mucosa. Aliment Pharmacol Ther 12: 1175\u20131184 ( 1998)","journal-title":"Aliment Pharmacol Ther"}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ja200864.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ja200864","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ja200864.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:13:42Z","timestamp":1684430022000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ja200864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":16,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["BFja200864"],"URL":"https:\/\/doi.org\/10.1038\/ja.2008.64","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}